Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) General Information
Description
Assets related to insulin resistance and related syndromes, including obesity in Chatham, New Jersey.
Contact Information
Corporate Office
- 26 Main Street
- Suite 101
- Chatham, NJ 07928
- United States
Corporate Office
- 26 Main Street
- Suite 101
- Chatham, NJ 07928
- United States
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) Patents
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019199704-A1 | Oxytocin compositions and methods of use | Inactive | 09-Apr-2018 |
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) FAQs
-
Where is Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) headquartered?
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) is headquartered in Chatham, NJ.
-
What industry is Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) in?
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)’s primary industry is Buildings and Property.
-
Is Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) a private or public company?
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) is a Private company.
-
What is the current valuation of Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)?
The current valuation of Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) is .
-
What is Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)’s current revenue?
The current revenue for Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) is .
-
Who are Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)’s investors?
Katana Pharmaceuticals has invested in Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey).
-
When was Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) acquired?
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) was acquired on 22-Dec-2020.
-
Who acquired Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)?
Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) was acquired by Tonix Pharmaceuticals Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process